Aline I. Riechardt
- Ophthalmology top 1%
- Radiology, Nuclear Medicine and Imaging top 5%
- Molecular Biology
- Public Health, Environmental and Occupational Health
- Oncology
- Co-authors
- Antonia M. JoussenIra SeibelDino CordiniA HagerEnken GundlachFranz H. GrusNils BoehmNorbert Pfeiffer
- Topics
- Ocular Oncology and Treatments (27 papers)Retinal and Macular Surgery (12 papers)Glaucoma and retinal disorders (11 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Aline I. Riechardt
38 papers receiving 746 citations
Peers
Comparison fields: 5 of 57
- Ophthalmology 569
- Radiology, Nuclear Medicine and Imaging 363
- Molecular Biology 147
- Public Health, Environmental and Occupational Health 128
- Oncology 91
Countries citing papers authored by Aline I. Riechardt
This map shows the geographic impact of Aline I. Riechardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aline I. Riechardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aline I. Riechardt more than expected).
Fields of papers citing papers by Aline I. Riechardt
This network shows the impact of papers produced by Aline I. Riechardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aline I. Riechardt. The network helps show where Aline I. Riechardt may publish in the future.
Co-authorship network of co-authors of Aline I. Riechardt
This figure shows the co-authorship network connecting the top 25 collaborators of Aline I. Riechardt. A scholar is included among the top collaborators of Aline I. Riechardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aline I. Riechardt. Aline I. Riechardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 7 | |
| 3 | 9 | |
| 4 | 11 | |
| 5 | 8 | |
| 6 | 18 | |
| 7 | 12 | |
| 8 | 30 | |
| 9 | 8 | |
| 10 | 31 | |
| 11 | 5 | |
| 12 | 28 | |
| 13 | 28 | |
| 14 | 7 | |
| 15 | 26 | |
| 16 | 7 | |
| 17 | 10 | |
| 18 | Netrin-4 mediates corneal neovascularization | 2 |
| 19 | 30 | |
| 20 | 28 |
About Aline I. Riechardt
Aline I. Riechardt is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 39 papers that have together received 767 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (27 papers), Retinal and Macular Surgery (12 papers) and Glaucoma and retinal disorders (11 papers). The work is most often cited by research in Ophthalmology (569 citations), Radiology, Nuclear Medicine and Imaging (363 citations) and Sensory Systems (24 citations). Aline I. Riechardt has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Antonia M. Joussen, Ira Seibel, Dino Cordini, A Hager, Enken Gundlach, Franz H. Grus, Nils Boehm, Norbert Pfeiffer, Jens Heufelder and Matúš Rehák. Their work appears in journals such as PLoS ONE, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.